Cite
HARVARD Citation
Brent, S. et al. (n.d.). EP206/#804 Rates of genetic testing in high grade serous ovarian cancer patients in the era of parp inhibitor therapy: a population-based study. International journal of gynecological cancer. p. A132. [Online].